|
|
Volumn 197, Issue 4303, 1977, Pages 527-532
|
|
Bioactivation as a model for drug design bioreductive alkylation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,4 BENZOQUINONE;
CAMPTOTHECIN;
DAUNORUBICIN;
DOXORUBICIN;
HYDROQUINONE;
KINAMYCIN;
MITOMYCIN C;
TYROTHRICIN;
ALKYLATION;
BOSTRYCIN I;
DRUG ACTIVATION;
DRUG DESIGN;
LOMASTILONE;
LOMAZARIN;
METHODOLOGY;
MODEL;
NANAOMYCIN;
ALKENES;
ALKYLATING AGENTS;
AMINES;
ANTIBIOTICS;
ANTIBIOTICS, ANTINEOPLASTIC;
BIOTRANSFORMATION;
CAMPTOTHECIN;
DAUNORUBICIN;
DOXORUBICIN;
LACTAMS;
LACTONES;
MITOMYCINS;
MODELS, CHEMICAL;
QUINONES;
STRUCTURE-ACTIVITY RELATIONSHIP;
SUPPORT, U.S. GOV'T, P.H.S.;
|
|
EID: 0017397793
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.877572 Document Type: Review |
|
Times cited : (544)
|
|
References (0)
|
